MNKD - MannKind Corporation

MNKD valuation $2.58 billion

Stock Price

6.35
Change: ↑ 0.07 (1.1146%)
Last Update: 2015-01-30T16:16:32-05:00
Shares Outstanding: 405,699,862
Industry: Biotechnology

MannKind Corporation is a biopharmaceutical company that focuses on the discovery, development and commercialization of therapeutic products for diseases such as diabetes and cancer.

Stock Price Data

Open: 6.27 Previous Close: 6.28
High: 6.54 Low: 6.20
Bid: 6.27 Ask: 6.35

Bid Size: 1200 Ask Size: 2000
Raw Bid Size: 12 Raw Ask Size: 20
Trade Volume: 14701 Share Volume: 5474184
Last Trade Date: 2015-01-30 Last Trade Time: 16:14:57-05:00
Vwap: 6.36039746 EPS: -0.58

Fundamental Data

PE ratio: PB ratio: -63.50
Beta: 1.070535

52 Week High: 11.48 52 Week Low: 3.80
52 Week High Vwap: 11.0769 52 Week Low Vwap: 4.1029
52 Week High Volume: 97393501 52 Week Low Volume: 1814602
52 Week Avg Volume: 8220306
* Quotes delayed 15 minutes

Related Stocks

StockCompany namePrice
GILD Gilead Sciences Inc. 104.83
IMGN ImmunoGen Inc. 7.63
CELG Celgene Corporation 119.16
ARNA Arena Pharmaceuticals Inc. 4.31
AMGN Amgen Inc 152.26
NVAX Novavax Inc. 7.81
BIIB Biogen Idec Inc. 389.16
NPSP NPS Pharmaceuticals Inc. 45.86
ARIA ARIAD Pharmaceuticals Inc. 6.45
PDLI PDL BioPharma Inc. 7.29